Study title: A randomized double-blind study evaluating the safety, tolerability and efficacy of SMOF 20% compared to Intralipid in premature infants
| Type of medicine: Herbal and homoeopathic medicines | |||||
| Therapeutic area: Nutritional and Metabolic Diseases [C18] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: REFINED SOYBEAN OIL; MEDIUM CHAINED TRIGLYCERIDES; REFINED OLIVE OIL; FISH OIL | |||||
| ATC code: B05B A02 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: 00-SMOF-004 | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| Y | Y | - | - | - | |